Prevalence and correlates of cannabis use in pregnancy and while breastfeeding: A survey-based study

2020 ◽  
Vol 42 (5) ◽  
pp. 677-678
Author(s):  
Kaija Kaarid ◽  
Nancy Vu ◽  
Katelyn Bartlett ◽  
Tejal Patel ◽  
Sapna Sharma ◽  
...  
Keyword(s):  
2020 ◽  
Vol 26 (10) ◽  
pp. 1515-1516 ◽  
Author(s):  
Anick Bérard
Keyword(s):  

2018 ◽  
Vol 131 (3) ◽  
pp. 594-595 ◽  
Author(s):  
Torri D. Metz
Keyword(s):  

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 413
Author(s):  
Kira Bombay ◽  
Malia SQ Murphy ◽  
Kathryn M Denize ◽  
Christina Cantin ◽  
Amy McGee ◽  
...  

Background: The prevalence of cannabis use among pregnant individuals in Canada is increasing. In the design of new cohort studies to evaluate the patterns and outcomes of cannabis use in pregnancy, consideration must be given to the factors influencing participation, data sharing, and contribution of biological samples. Our objective was to assess the willingness of pregnant individuals to participate in prospective research during pregnancy. Methods: We surveyed pregnant individuals receiving obstetrical care through The Ottawa Hospital in Ottawa, Canada. The survey consisted of 23 dichotomous (yes/no), multiple-choice, Likert scale, and open-ended questions. Individuals were provided with a hypothetical research scenario and asked to report on the likelihood of their participation, use and storage of personal health information and contribution of maternal and newborn samples. Individuals provided motivating and deterring factors related to research participation. Descriptive statistics included frequencies (n) and percentages (%) for categorical variables. Continuous variables were described using means and standard deviations. Results: A total of 84 survey responses were collected. The mean age of respondents was 32.6(±5.3) years. Respondents were predominantly Caucasian (79%), college/university educated (85%) with a household income of ≥$100,000 (64%). There was a high degree of willingness to participate in prospective research by sharing data and biological samples. The most commonly cited motivating and deterring factors for participating in future research were a desire to contribute to science and health information (79%) and fear of privacy invasion (17%), respectively. Conclusions: Pregnant individuals receiving care at The Ottawa Hospital are willing to participate in prospective research studies, including those related to cannabis use. Survey respondents were predominantly of higher socioeconomic status, and few individuals reported cannabis use during pregnancy. Future studies should accommodate multiple recruitment strategies and flexible study designs to encourage enrollment from and retention across diverse sociodemographic communities.


2015 ◽  
Vol 57 ◽  
pp. 218-219
Author(s):  
Jorgos Eleftheriou ◽  
Rafaella Butera ◽  
Mariapina Gallo ◽  
Lorella Faraoni ◽  
Gioia Contessa ◽  
...  

JAMA ◽  
2019 ◽  
Vol 322 (2) ◽  
pp. 121 ◽  
Author(s):  
Michael Silverstein ◽  
Elizabeth A. Howell ◽  
Barry Zuckerman
Keyword(s):  

2020 ◽  
Vol 153 (2) ◽  
pp. 95-100
Author(s):  
Erin Davis ◽  
Tiffany Lee ◽  
John T. Weber ◽  
Shawn Bugden

Background: The recent legalization of cannabis use in Canada requires pharmacists to be able to support their patients with accurate knowledge of its known risks and benefits. Certain populations, such as pregnant and breastfeeding women and their developing children, may be at higher risk than other populations. Methods: The authors independently searched the literature for clinical reports or reviews of the literature regarding the safety of cannabis use in pregnancy and breastfeeding using search terms such as cannabis, marijuana, pregnancy and breastfeeding. Results: This review combines the relevant pharmacological, pharmacokinetic and clinical evidence for the effects of cannabis in this special patient population. The literature demonstrates that some of the constituents of cannabis can reach children in utero and through breastmilk. Given that Δ⁹-tetrahydrocannabinol can be present in breastmilk as quickly as 1 hour after consumption and last up to 6 days, it may not be possible to use cannabis and avoid infant exposure. There is evidence that this exposure may result in cognitive, social and motor defects. Some of these effects may be long term, lasting years. The pharmacist must be able to educate and screen patients regarding marijuana use in pregnancy and breastfeeding, with the ultimate aim of harm reduction.


Author(s):  
D. Scott Howard ◽  
David N. Dhanraj ◽  
C. Ganga Devaiah ◽  
Donna S. Lambers

2019 ◽  
Vol 41 (9) ◽  
pp. 1311-1317 ◽  
Author(s):  
Sabrina Luke ◽  
Jennifer Hutcheon ◽  
Tamil Kendall

Sign in / Sign up

Export Citation Format

Share Document